Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Journal of Toxicology and Environmental Health. Part A|August 10, 2007
14C-labeled pulegone and metabolites binding to alpha2u-globulin in kidneys of male F-344 ratsLing-Jen Chen Ferguson, Edward H Lebetkin, Fred B Lih, et al.
European Journal of Immunology|October 1, 1989
Analysis of human T cell response to two Plasmodium falciparum merozoite surface antigensC M Rzepczyk, R Ramasamy, D A Mutch, et al.
Journal of Occupational and Environmental Medicine|February 5, 2022
A Career Life-Cycle Perspective on Women's Health and Safety: Insights From the Defense Health Board Report on Military Women's HealthRobert S Kaplan, Chizoba L Chukwura, Gregory H Gorman, et al.
Pharmaceutical Medicine|May 23, 2025
A Model for an Academia-Industry Collaboration for Pharmacovigilance and PharmacoepidemiologyAlfred I Neugut, Vinu George, Judith S Jacobson, et al.
Journal of Genetic Counseling|July 12, 2019
The impact of genetic counseling on patient engagement in a specialty cancer clinicAnna L Zakas, Claire Leifeste, Beth Dudley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanomaJ P Dutcher, S Creekmore, G R Weiss, et al.
The Journal of Infectious Diseases|April 1, 1990
An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cellsI B Weisfuse, D J Graham, M Will, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1993
Identification of a subpopulation of reactive large granular mononuclear cells in allogeneic heart transplantationP W Tsao, G B Mills, R J Diaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim reportJ C Yang, S L Topalian, D Parkinson, et al.
Pageof 16